M28 Capital Management LP — 13F Holdings & Portfolio

CIK 1807489 · latest 13F-HR filed 2026-08-13

M28 Capital Management LP manages $47.2M in 13F-reported U.S. long-equity assets across 9 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are WVE (56.53%), IVVD (17.11%), TGTX (10.29%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 0 new positions, exited 0, added to 5, and trimmed 2.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Filer Information
Address
700 CANAL STREET, 1ST FLOOR
STAMFORD, CT 06902
Phone
(203) 516-3730
Filing Manager
M28 Capital Management LP
STAMFORD, CT
Signatory
Marc Elia
Chief Investment Officer
Loading holdings…
AUM

$47.2M

Long-equity book

Holdings

9

Distinct positions

Period

2026-06-30

Filed 2026-08-13

Q/Q Activity

+0 / −0 / ↑5 / ↓2

vs 2026-03-31

Firm Profile & Key People
Name Title / Status Ownership Type

Top Adds (vs prior quarter)

  • TG THERAPEUTICS INC$1.9M +65.4%
  • ARROWHEAD PHARMACEUTICALS IN$693.2K +30.0%
  • FRACTYL HEALTH INC$624.8K +73.5%
  • SILENCE THERAPEUTICS PLC$577.9K +108.3%
  • PROQR THRAPEUTICS N V$143.9K +14.8%
Show all 5

Top Trims

  • WAVE LIFE SCIENCES LTD-$6.6M -19.9%
  • INVIVYD INC-$4.0M -32.9%
Show all 2

New Positions

  • No new positions this quarter.
Show all 0

Exited Positions

  • No exits this quarter.
Show all 0
All Holdings

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 WAVE LIFE SCIENCES LTD WVE Y95308105 $26.7M 56.53% 4,588,284 SH
2 INVIVYD INC IVVD 00534A102 $8.1M 17.11% 9,248,250 SH
3 TG THERAPEUTICS INC TGTX 88322Q108 $4.9M 10.29% 88,354 SH
4 ARROWHEAD PHARMACEUTICALS IN ARWR 04280A100 $3.0M 6.37% 36,851 SH
5 FRACTYL HEALTH INC GUTS 35168W103 $1.5M 3.13% 1,856,117 SH
6 PROQR THRAPEUTICS N V PRQR N71542109 $1.1M 2.37% 599,793 SH
7 SILENCE THERAPEUTICS PLC SLN 82686Q101 $1.1M 2.36% 101,203 SH
8 ROCKET PHARMACEUTICALS INC RCKT 77313F106 $721.2K 1.53% 210,871 SH
9 CURIS INC CRIS 231269309 $148.7K 0.32% 284,889 SH
Filing History
Period Filed AUM Holdings Accession
2026-06-30 2026-08-13 $47.2M 9 0000902664-26-003441
2026-03-31 2026-05-14 $53.8M 9 0000902664-26-002442
2025-12-31 2026-02-13 $137.6M 9 0000902664-26-000993
2025-09-30 2025-11-13 $68.0M 9 0000902664-25-004910